Danaher Corporation (DHR) Stock Price: $188.41+4.88 (+2.66%)
The total return cagr for Danaher Corporation (DHR) stock is -4.76% over the past 12 months. The 3 year average growth rate is -2.82% and the 5 year cagr is -2.00%. Total return includes dividends reinvested.
The closing share price for Danaher Corporation (DHR) stock was $188.41 for Tuesday, June 9, 2026, up +2.66% from the previous day.
DHR Price Chart
DHR Key Metrics
See All MetricsDHR Earnings Preview
Next Earnings Date
Jul 21, 2026
42 days away
EPS Estimate
1.83
Revenue Est.
$6.09B
Last Quarter Results
EPS
$2.06
vs Estimate
$1.94
Revenue
$5.95B
vs Estimate
$5.98B
DHR Analyst Ratings
Consensus Rating
Based on 22 analysts
Average Price Target
$244.27
+29.6% upside
Low
$200.00
Current
$188.41
High
$310.00
DHR Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $2.16 | N/A | 6 |
| Q2 2027 | N/A | $2.03 | N/A | 12 |
| Q3 2027 | N/A | $2.19 | N/A | 6 |
| Q4 2027 | N/A | $2.68 | N/A | 10 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $9.10 | N/A | 14 |
| FY 2028 | N/A | $9.96 | N/A | 5 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $6.33B | N/A | 6 |
| Q2 2027 | N/A | $6.50B | N/A | 12 |
| Q3 2027 | N/A | $6.65B | N/A | 6 |
| Q4 2027 | N/A | $7.59B | N/A | 10 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $27.06B | N/A | 14 |
| FY 2028 | N/A | $28.91B | N/A | 5 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
DHR Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1DHR | $133.37B | $188.41 | +2.66% | -4.76% | -2.00% | +14.71% |
DHR Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair